查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
幹細胞治療藥的受託製造的全球市場:2023-2033年
市場調查報告書
商品編碼
1347800

幹細胞治療藥的受託製造的全球市場:2023-2033年

Stem Cell Therapy Contract Manufacturing Market Report 2023-2033
出版日期: | 出版商: Visiongain Reports Ltd. | 英文 310 Pages | 商品交期: 最快1-2個工作天內

價格

全球幹細胞治療藥的受託製造的市場規模到2033年前將以12.4％的年複合成長率成長。

細胞生物學和再生醫學領域的進步為旨在治療各種心血管、腫瘤、代謝和肌肉骨骼疾病的幹細胞療法的出現奠定了堅實的基礎。這些創新療法為世界各地的患者帶來了光明的前景，並有望改變應對複雜醫療挑戰的策略和策略。相信在這一領域的不斷探索和努力將在有效控制和根除疾病方面取得進展。

本報告提供全球幹細胞治療藥的受託製造的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場概要

  • 主要調查結果
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • COVID-19影響分析
  • 波特的五力分析
  • PEST分析

第4章 按幹細胞治療藥的受託製造市場分析:事業規模

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 商業
  • 臨床
  • 前臨床

第5章 幹細胞治療藥的受託製造市場分析:受託製造商的各規模

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 大規模/超大規模
  • 中規模
  • 小規模

第6章 按幹細胞治療藥的受託製造市場分析:幹細胞供給來源

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 同類幹細胞
  • 自體幹細胞

第7章 幹細胞治療藥的受託製造市場分析:幹細胞各類型

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 成人幹細胞
  • 人類胚胎幹細胞 (HESC)
  • 誘導性多功能幹細胞 (iPSC)

第8章 幹細胞治療藥的受託製造市場分析:各終端用戶

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的估計·預測
  • 生物醫藥品企業
  • 研究機關
  • 其他

第9章 幹細胞治療藥的受託製造市場分析:各地區

  • 主要調查結果
  • 市場規模的轉變·預測

第10章 北美的幹細胞治療藥的受託製造市場分析

第11章 歐洲的幹細胞治療藥的受託製造市場分析

第12章 亞太地區的幹細胞治療藥的受託製造市場分析

第13章 南美的幹細胞治療藥的受託製造市場分析

第14章 中東·非洲的幹細胞治療藥的受託製造市場分析

第15章 企業簡介

  • 企業佔有率分析
  • 策略性展望
  • AbbVie Inc.
  • AGC Biologics
  • Boehringer Ingelheim GmbH
  • Catalent Inc.
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Pfizer Inc.
  • Samsung Biologics
  • WuXi AppTec
  • Thermo Fisher Scientific Inc.
  • Cytiva

第16章 總論·建議

Product Code: PHA1279

The global Stem Cell Therapy Contract Manufacturing market is projected to grow at a CAGR of 12.4% by 2033.

“The Stem Cell Therapy Contract Manufacturing Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advances in Cell Biology and Regenerative Medicine Propels Stem Cell Therapy Market Consequently boosting the Contract Manufacturing market

The progress in the realm of cell biology and regenerative medicine has laid a solid foundation for the emergence of therapies centered on stem cells, aimed at addressing an array of cardiovascular, oncological, metabolic, and musculoskeletal disorders. These innovative treatments hold promise for patients across the globe, presenting the prospect of transforming our strategies and tactics for handling these intricate medical challenges. Sustained exploration and inventive endeavours within this domain will undeniably lead to additional milestones, propelling us towards a tomorrow in which incapacitating illnesses can be managed with effectiveness, and in some cases, even eradicated. For instance, Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics are using CRISPR-Cas9 gene editing technology for potential gene therapies and regenerative medicine applications, aiming to correct genetic disorders at the molecular level. Also, Vericel's MACI (Matrix-Induced Autologous Chondrocyte Implantation) is an FDA-approved product that uses a patient's own cells to repair cartilage defects in the knee.

Challenges Posed by Immunogenicity and Potential for Rejection in Stem Cell Therapy is Restraining the Market Growth

Immunogenicity-related issues encountered during clinical trials can result in trial delays, the need for further research, and adjustments to therapy design. These setbacks have the potential to extend the development timeline and elevate costs, possibly deterring investments and impeding market expansion. Should stem cell therapies be prone to immune rejection, their sustained effectiveness and durability might be compromised. This has the potential to erode patient trust in the therapy and curtail the market demand for treatments lacking enduring advantages. The challenges posed by immunogenicity and the prospect of rejection in stem cell therapy can significantly influence market growth. Immunogenicity pertains to the capacity of stem cell therapies to trigger immune reactions within recipients. These responses may lead to the rejection of transplanted cells, curbing therapy efficacy and raising safety concerns. Patients experiencing rejection may not attain the intended therapeutic outcomes, resulting in less-than-optimal treatment results.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the stem cell therapy contract manufacturing market evolving?
  • What is driving and restraining the stem cell therapy contract manufacturing market?
  • How will each stem cell therapy contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each stem cell therapy contract manufacturing submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading stem cell therapy contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the stem cell therapy contract manufacturing projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of stem cell therapy contract manufacturing projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the stem cell therapy contract manufacturing market?
  • Where is the stem cell therapy contract manufacturing market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the stem cell therapy contract manufacturing market today, and over the next 10 years:

  • Our 310-page report provides 111 tables and 185 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Stem Cell Therapy Contract Manufacturing Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Scale of Operation Outlook

  • Commercial
  • Clinical
  • Preclinical

Size of Contract Manufacturer

  • Large/Very Large
  • Mid-sized
  • Small-sized

Source of Stem Cells

  • Allogenic
  • Autologous

Type of Stem Cells

  • Adult Stem Cells (ASCs)
  • Human Embryonic Stem Cells (HESCs)
  • Induced Pluripotent Stem Cells (iPSCs)

End-user

  • Biopharmaceutical companies
  • Research Institutes
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Stem Cell Therapy Contract Manufacturing Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • AbbVie Inc
  • AGC Biologics
  • Boehringer Ingelheim GmbH
  • Catalent Inc
  • Cytiva
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Samsung Biologics
  • Thermo Fisher Scientific Inc
  • WuXi AppTec

Overall world revenue for Stem Cell Therapy Contract Manufacturing Market, 2023 to 2033 in terms of value the market will surpass US$2,752.1 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Stem Cell Therapy Contract Manufacturing Market, 2023 to 2033 report help you?

In summary, our 310-page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Stem Cell Therapy Contract Manufacturing Market, 2023 to 2033 Market, with forecasts for scale of operation, size of contract manufacturer, source of stem cells, type of stem cells, and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Stem Cell Therapy Contract Manufacturing Market, 2023 to 2033 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Stem Cell Therapy Contract Manufacturing Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Stem Cell Therapy Contract Manufacturing Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Stem Cell Therapy Contract Manufacturing Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Product Development of Stem Cell Therapy Driving the Demand for Contract Manufacturing Solutions
      • 3.2.1.2 Growing Venture Capital Investments in Stem Cell Based Therapies
      • 3.2.1.3 Supportive Regulations Pertinent to the Development of Stem Cell Therapy Contract Manufacturing
      • 3.2.1.4 Rising Prevalence of Chronic Diseases
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Complex Manufacturing Process
      • 3.2.2.2 Challenges Posed by Immunogenicity and the Potential for Rejection in Stem Cell Therapy
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Strong Product Pipeline
      • 3.2.3.2 Advancements in Stem Cell Therapy Manufacturing Process
      • 3.2.3.3 Advances in Cell Biology and Regenerative Medicine
      • 3.2.3.4 Collaboration and M&A Driving the Market Growth
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Stem Cell Therapy Contract Manufacturing Market Analysis by Scale of Operation

  • 4.1 Key Findings
  • 4.2 Scale of Operation Segment: Market Attractiveness Index
  • 4.3 Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
  • 4.4 Commercial
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Clinical
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6 Pre-clinical
    • 4.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.6.2 Market Share by Region, 2023 & 2033 (%)

5 Stem Cell Therapy Contract Manufacturing Market Analysis by Size of Contract Manufacturer

  • 5.1 Key Findings
  • 5.2 Size of Contract Manufacturer Segment: Market Attractiveness Index
  • 5.3 Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Size of Contract Manufacturer
  • 5.4 Large/Very Large Contract Manufacturers
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Mid-Sized Contract Manufacturers
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Small-sized Contract Manufacturers
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Stem Cell Therapy Contract Manufacturing Market Analysis by Source of Stem Cells

  • 6.1 Key Findings
  • 6.2 Source of Stem Cells Segment: Market Attractiveness Index
  • 6.3 Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Source of Stem Cells
  • 6.4 Allogenic Stem Cells
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Autologous Stem Cells
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Stem Cell Therapy Contract Manufacturing Market Analysis by Type of Stem Cells

  • 7.1 Key Findings
  • 7.2 Type of Stem Cells Segment: Market Attractiveness Index
  • 7.3 Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Type of Stem Cells
  • 7.4 Adult Stem Cells
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Human Embryonic Stem Cells (HESCs)
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Induced Pluripotent Stem Cells (iPSCs)
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)

8 Stem Cell Therapy Contract Manufacturing Market Analysis by End-User

  • 8.1 Key Findings
  • 8.2 End-User Segment: Market Attractiveness Index
  • 8.3 Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by End-User
  • 8.4 Biopharmaceutical Companies
    • 8.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Research Institutes
    • 8.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Others
    • 8.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)

9 Stem Cell Therapy Contract Manufacturing Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Stem Cell Therapy Contract Manufacturing Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • 10.3 North America Stem Cell Therapy Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 10.4 North America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Country
  • 10.5 North America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
  • 10.6 North America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Size of Contract Manufacturer
  • 10.7 North America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Source of Stem Cells
  • 10.8 North America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Type of Stem Cells
  • 10.9 North America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by End-user
  • 10.10 U.S. Stem Cell Therapy Contract Manufacturing Market Analysis
  • 10.11 Canada Stem Cell Therapy Contract Manufacturing Market Analysis

11 Europe Stem Cell Therapy Contract Manufacturing Market Analysis

  • 11.1 Key Findings
  • 11.2 Europe Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • 11.3 Europe Stem Cell Therapy Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 Europe Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Country
  • 11.5 Europe Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
  • 11.6 Europe Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Size of Contract Manufacturer
  • 11.7 Europe Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Source of Stem Cells
  • 11.8 Europe Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Type of Stem Cells
  • 11.9 Europe Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by End-user
  • 11.10 Germany Stem Cell Therapy Contract Manufacturing Market Analysis
  • 11.11 UK Stem Cell Therapy Contract Manufacturing Market Analysis
  • 11.12 France Stem Cell Therapy Contract Manufacturing Market Analysis
  • 11.13 Italy Stem Cell Therapy Contract Manufacturing Market Analysis
  • 11.14 Spain Stem Cell Therapy Contract Manufacturing Market Analysis
  • 11.15 Russia Stem Cell Therapy Contract Manufacturing Market Analysis
  • 11.16 Rest of Europe Stem Cell Therapy Contract Manufacturing Market Analysis

12 Asia Stem Cell Therapy Contract Manufacturing Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • 12.3 Asia Stem Cell Therapy Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 Asia Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Country
  • 12.5 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
  • 12.6 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Size of Contract Manufacturer
  • 12.7 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Source of Stem Cells
  • 12.8 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Type of Stem Cells
  • 12.9 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by End-user
  • 12.10 Japan Stem Cell Therapy Contract Manufacturing Market Analysis
  • 12.11 China Stem Cell Therapy Contract Manufacturing Market Analysis
  • 12.12 India Stem Cell Therapy Contract Manufacturing Market Analysis
  • 12.13 Australia Stem Cell Therapy Contract Manufacturing Market Analysis
  • 12.14 South Korea Stem Cell Therapy Contract Manufacturing Market Analysis
  • 12.15 Rest of Asia Stem Cell Therapy Contract Manufacturing Market Analysis

13 Latin America Stem Cell Therapy Contract Manufacturing Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • 13.3 Latin America Stem Cell Therapy Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 Latin America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Country
  • 13.5 Latin America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
  • 13.6 Latin America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Size of Contract Manufacturer
  • 13.7 Latin America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Source of Stem Cells
  • 13.8 Latin America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Type of Stem Cells
  • 13.9 Latin America Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by End-user
  • 13.10 Brazil Stem Cell Therapy Contract Manufacturing Market Analysis
  • 13.11 Mexico Stem Cell Therapy Contract Manufacturing Market Analysis
  • 13.12 Argentina Stem Cell Therapy Contract Manufacturing Market Analysis
  • 13.13 Rest of Latin America Stem Cell Therapy Contract Manufacturing Market Analysis

14 MEA Stem Cell Therapy Contract Manufacturing Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • 14.3 MEA Stem Cell Therapy Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 14.4 MEA Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Country
  • 14.5 MEA Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
  • 14.6 MEA Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Size of Contract Manufacturer
  • 14.7 MEA Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Source of Stem Cells
  • 14.8 MEA Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by Type of Stem Cells
  • 14.9 MEA Stem Cell Therapy Contract Manufacturing Market Size Estimation and Forecast by End-user
  • 14.10 GCC Stem Cell Therapy Contract Manufacturing Market Analysis
  • 14.11 South Africa Stem Cell Therapy Contract Manufacturing Market Analysis
  • 14.12 Rest of MEA Stem Cell Therapy Contract Manufacturing Market Analysis

15 Company Profiles

  • 15.1 Company Share Analysis, 2022
  • 15.2 Strategic Outlook
  • 15.3 AbbVie Inc.
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2017-2022
      • 15.3.3.2 R&D, 2017-2022
      • 15.3.3.3 Regional Market Shares, 2022
    • 15.3.4 Service Benchmarking
    • 15.3.5 Strategic Outlook
  • 15.4 AGC Biologics
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
    • 15.4.4 Service Benchmarking
    • 15.4.5 Strategic Outlook
  • 15.5 Boehringer Ingelheim GmbH
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Financial Analysis
      • 15.5.3.1 Net Revenue, 2017-2022
      • 15.5.3.2 R&D, 2017-2022
      • 15.5.3.3 Segment Market Shares, 2022
      • 15.5.3.4 Regional Market Shares, 2022
    • 15.5.4 Service Benchmarking
    • 15.5.5 Strategic Outlook
  • 15.6 Catalent Inc.
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
      • 15.6.3.1 Net Revenue, 2017-2022
      • 15.6.3.2 R&D, 2017-2022
      • 15.6.3.3 Segment Market Shares, 2022
      • 15.6.3.4 Regional Market Shares, 2022
    • 15.6.4 Service Benchmarking
    • 15.6.5 Strategic Outlook
  • 15.7 FUJIFILM Diosynth Biotechnologies
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
    • 15.7.4 Service Benchmarking
    • 15.7.5 Strategic Outlook
  • 15.8 Lonza
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2017-2022
      • 15.8.3.2 R&D, 2017-2022
      • 15.8.3.3 Segment Market Shares, 2022
      • 15.8.3.4 Regional Market Shares, 2022
    • 15.8.4 Service Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 Pfizer Inc.
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Financial Analysis
      • 15.9.3.1 Net Revenue, 2017-2022
      • 15.9.3.2 R&D, 2017-2022
      • 15.9.3.3 Segment Market Shares, 2022
      • 15.9.3.4 Regional Market Shares, 2022
    • 15.9.4 Service Benchmarking
    • 15.9.5 Strategic Outlook
  • 15.10 Samsung Biologics
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2017-2022
      • 15.10.3.2 Segment Market Shares, 2022
      • 15.10.3.3 Regional Market Shares, 2022
    • 15.10.4 Service Benchmarking
    • 15.10.5 Strategic Outlook
  • 15.11 WuXi AppTec
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Financial Analysis
      • 15.11.3.1 Net Revenue, 2017-2022
      • 15.11.3.2 Segment Market Shares, 2022
    • 15.11.4 Service Benchmarking
    • 15.11.5 Strategic Outlook
  • 15.12 Thermo Fisher Scientific Inc.
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Financial Analysis
      • 15.12.3.1 Net Revenue, 2017-2022
      • 15.12.3.2 R&D, 2017-2022
      • 15.12.3.3 Segment Market Shares, 2022
      • 15.12.3.4 Regional Market Shares, 2022
    • 15.12.4 Service Benchmarking
    • 15.12.5 Strategic Outlook
  • 15.13 Cytiva
    • 15.13.1 Company Snapshot
    • 15.13.2 Company Overview
    • 15.13.3 Financial Analysis
      • 15.13.3.1 Net Revenue, 2017-2022
      • 15.13.3.2 R&D, 2017-2022
      • 15.13.3.3 Segment Market Shares, 2022
      • 15.13.3.4 Regional Market Shares, 2022
    • 15.13.4 Service Benchmarking
    • 15.13.5 Strategic Outlook

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from
  • 16.2 Recommendations for Market Players

List of Tables

  • Table 1 Stem Cell Therapy Contract Manufacturing Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
  • Table 2 Strategic Outlook
  • Table 3 Stem Cell Therapy Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 4 Stem Cell Therapy Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 5 Stem Cell Therapy Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 6 Stem Cell Therapy Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 7 Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 8 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 9 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 10 Pre-clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 11 Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 12 Large/Very Large Contract Manufacturer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 13 Mid-Sized Contract Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 14 Small-sized Contract Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 15 Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 16 Allogenic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 17 Autologous Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 18 Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 19 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 20 Human Embryonic Stem Cells (HESCs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 21 Induced Pluripotent Stem Cells (iPSCs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 22 Stem Cell Therapy Contract Manufacturing Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 23 Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 24 Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 25 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 26 Stem Cell Therapy Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 27 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 28 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 29 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 30 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 31 Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 32 Stem Cell Therapy Contract Manufacturing Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 33 U.S. Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 34 Canada Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 35 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 36 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 37 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 38 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 39 Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 40 Stem Cell Therapy Contract Manufacturing Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 41 Germany Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 42 UK Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 43 France Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 44 Italy Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 45 Spain Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 46 Russia Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 47 Rest of Europe Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 48 Asia Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 49 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 50 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 51 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 52 Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 53 Stem Cell Therapy Contract Manufacturing Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 54 Japan Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 55 China Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 56 India Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 57 Australia Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 58 .South Korea Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 59 Rest of Asia Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 60 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 61 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 62 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 63 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 64 Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 65 Stem Cell Therapy Contract Manufacturing Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 66 Brazil Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 67 Mexico Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 68 Argentina Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 69 Rest of Latin America Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 70 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 71 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 72 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 73 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 74 Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 75 Stem Cell Therapy Contract Manufacturing Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 76 GCC Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 77 South Africa Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 78 Rest of MEA Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 79 Strategic Outlook
  • Table 80 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 AbbVie Inc.: Service Benchmarking
  • Table 82 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 AGC Biologics: Service Benchmarking
  • Table 84 AGC Biologics: Strategic Outlook
  • Table 85 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 Boehringer Ingelheim GmbH: Service Benchmarking
  • Table 87 Boehringer Ingelheim GmbH: Strategic Outlook
  • Table 88 Catalent Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Catalent Inc.: Service Benchmarking
  • Table 90 Catalent Inc.: Strategic Outlook
  • Table 91 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
  • Table 93 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
  • Table 94 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Lonza: Service Benchmarking
  • Table 96 Lonza: Strategic Outlook
  • Table 97 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Pfizer Inc.: Service Benchmarking
  • Table 99 Pfizer Inc.: Strategic Outlook
  • Table 100 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Samsung Biologics: Service Benchmarking
  • Table 102 Samsung Biologics: Strategic Outlook
  • Table 103 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 WuXi AppTec: Service Benchmarking
  • Table 105 WuXi AppTec: Strategic Outlook
  • Table 106 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Thermo Fisher Scientific Inc.: Service Benchmarking
  • Table 108 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 109 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Cytiva: Service Benchmarking
  • Table 111 Cytiva: Strategic Outlook
  •  

List of Figures

  • Figure 1 Stem Cell Therapy Contract Manufacturing Market Segmentation
  • Figure 2 Stem Cell Therapy Contract Manufacturing Market by Scale of Operation: Market Attractiveness Index
  • Figure 3 Stem Cell Therapy Contract Manufacturing Market by Size of Contract Manufacturer: Market Attractiveness Index
  • Figure 4 Stem Cell Therapy Contract Manufacturing Market by Source of Stem Cells Market Attractiveness Index
  • Figure 5 Stem Cell Therapy Contract Manufacturing Market by Type of Stem Cells Market Attractiveness Index
  • Figure 6 Stem Cell Therapy Contract Manufacturing Market by End-user: Market Attractiveness Index
  • Figure 7 Stem Cell Therapy Contract Manufacturing Market Attractiveness Index by Region
  • Figure 8 Stem Cell Therapy Contract Manufacturing Market: Market Dynamics
  • Figure 9 Stem Cell Therapy Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 10 Stem Cell Therapy Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 11 Stem Cell Therapy Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 12 Stem Cell Therapy Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 13 Stem Cell Therapy Contract Manufacturing Market: Porter's Five Forces Analysis
  • Figure 14 Stem Cell Therapy Contract Manufacturing Market: PEST Analysis
  • Figure 15 Stem Cell Therapy Contract Manufacturing Market by Scale of Operation: Market Attractiveness Index
  • Figure 16 Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 17 Stem Cell Therapy Contract Manufacturing Share Forecast by Scale of Operation, 2023, 2028, 2033 (%)
  • Figure 18 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 19 Commercial Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 20 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 21 Clinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 Pre-clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 23 Pre-clinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 24 Stem Cell Therapy Contract Manufacturing Market by Size of Contract Manufacturer: Market Attractiveness Index
  • Figure 25 Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR %)
  • Figure 26 Stem Cell Therapy Contract Manufacturing Share Forecast by Size of Contract Manufacturer, 2023, 2028, 2033 (%)
  • Figure 27 Large/Very Large Contract Manufacturer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 28 Large/Very Large Contract Manufacturer Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Mid-Sized Contract Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 30 Mid-Sized Contract Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 31 Small-sized Contract Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 32 Small-sized Contract Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 33 Stem Cell Therapy Contract Manufacturing Market by Source of Stem Cells: Market Attractiveness Index
  • Figure 34 Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 35 Stem Cell Therapy Contract Manufacturing Share Forecast by Source of Stem Cells, 2023, 2028, 2033 (%)
  • Figure 36 Allogenic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 37 Allogenic Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Autologous Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 39 Autologous Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 40 Stem Cell Therapy Contract Manufacturing Market by Type of Stem Cells: Market Attractiveness Index
  • Figure 41 Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 42 Stem Cell Therapy Contract Manufacturing Share Forecast by Type of Stem Cells, 2023, 2028, 2033 (%)
  • Figure 43 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 44 Adult Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 45 Human Embryonic Stem Cells (HESCs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 46 Human Embryonic Stem Cells (HESCs) Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 47 Induced Pluripotent Stem Cells (iPSCs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 48 Induced Pluripotent Stem Cells (iPSCs) Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 49 Stem Cell Therapy Contract Manufacturing Market by End-User: Market Attractiveness Index
  • Figure 50 Stem Cell Therapy Contract Manufacturing Market Forecast by End-User, 2023-2033 (US$ Million, AGR %)
  • Figure 51 Stem Cell Therapy Contract Manufacturing Share Forecast by End-User, 2023, 2028, 2033 (%)
  • Figure 52 Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 53 Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 54 Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 55 Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 56 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 57 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 58 Stem Cell Therapy Contract Manufacturing Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
  • Figure 59 Stem Cell Therapy Contract Manufacturing Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 60 Stem Cell Therapy Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 61 North America Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • Figure 62 North America Stem Cell Therapy Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 63 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 64 North America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 65 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 66 North America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
  • Figure 67 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR %)
  • Figure 68 North America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Size of Contract Manufacturer, 2023 & 2033 (%)
  • Figure 69 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 70 North America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Source of Stem Cells, 2023 & 2033 (%)
  • Figure 71 North America Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 72 North America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Type of Stem Cells, 2023 & 2033 (%)
  • Figure 73 North America Stem Cell Therapy Contract Manufacturing Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 74 North America Stem Cell Therapy Contract Manufacturing Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 75 U.S. Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 76 Canada Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 77 Europe Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • Figure 78 Europe Stem Cell Therapy Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 79 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 80 Europe Stem Cell Therapy Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 81 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 82 Europe Stem Cell Therapy Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
  • Figure 83 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR %)
  • Figure 84 Europe Stem Cell Therapy Contract Manufacturing Market Share Forecast by Size of Contract Manufacturer, 2023 & 2033 (%)
  • Figure 85 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 86 Europe Stem Cell Therapy Contract Manufacturing Market Share Forecast by Source of Stem Cells, 2023 & 2033 (%)
  • Figure 87 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 88 Europe Stem Cell Therapy Contract Manufacturing Market Share Forecast by Type of Stem Cells, 2023 & 2033 (%)
  • Figure 89 Europe Stem Cell Therapy Contract Manufacturing Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 90 Europe Stem Cell Therapy Contract Manufacturing Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 91 Germany Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 92 UK Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 93 France Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 94 Italy Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 95 Spain Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 96 Russia Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 97 Rest of Europe Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 98 Asia Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • Figure 99 Asia Stem Cell Therapy Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 100 Asia Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 101 Asia Stem Cell Therapy Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 102 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 103 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
  • Figure 104 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR %)
  • Figure 105 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Share Forecast by Size of Contract Manufacturer, 2023 & 2033 (%)
  • Figure 106 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 107 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Share Forecast by Source of Stem Cells, 2023 & 2033 (%)
  • Figure 108 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 109 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Share Forecast by Type of Stem Cells, 2023 & 2033 (%)
  • Figure 110 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 111 Asia Pacific Stem Cell Therapy Contract Manufacturing Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 112 Japan Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 113 China Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 114 India Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 115 Australia Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 116 South Korea Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 117 Rest of Asia Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 118 Latin America Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • Figure 119 Latin America Stem Cell Therapy Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 120 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 121 Latin America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 122 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 123 Latin America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
  • Figure 124 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR %)
  • Figure 125 Latin America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Size of Contract Manufacturer, 2023 & 2033 (%)
  • Figure 126 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 127 Latin America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Source of Stem Cells, 2023 & 2033 (%)
  • Figure 128 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 129 Latin America Stem Cell Therapy Contract Manufacturing Market Share Forecast by Type of Stem Cells, 2023 & 2033 (%)
  • Figure 130 Latin America Stem Cell Therapy Contract Manufacturing Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 131 Latin America Stem Cell Therapy Contract Manufacturing Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 132 Brazil Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 133 Mexico Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 134 Argentina Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 135 Rest of Latin America Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 136 MEA Stem Cell Therapy Contract Manufacturing Market Attractiveness Index
  • Figure 137 MEA Stem Cell Therapy Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 138 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 139 MEA Stem Cell Therapy Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 140 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 141 MEA Stem Cell Therapy Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
  • Figure 142 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Size of Contract Manufacturer, 2023-2033 (US$ Million, AGR %)
  • Figure 143 MEA Stem Cell Therapy Contract Manufacturing Market Share Forecast by Size of Contract Manufacturer, 2023 & 2033 (%)
  • Figure 144 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Source of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 145 MEA Stem Cell Therapy Contract Manufacturing Market Share Forecast by Source of Stem Cells, 2023 & 2033 (%)
  • Figure 146 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by Type of Stem Cells, 2023-2033 (US$ Million, AGR %)
  • Figure 147 MEA Stem Cell Therapy Contract Manufacturing Market Share Forecast by Type of Stem Cells, 2023 & 2033 (%)
  • Figure 148 MEA Stem Cell Therapy Contract Manufacturing Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 149 MEA Stem Cell Therapy Contract Manufacturing Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 150 GCC Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 151 South Africa Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 152 Rest of MEA Stem Cell Therapy Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 153 Stem Cell Therapy Contract Manufacturing Market: Company Share Analysis, 2022
  • Figure 154 AbbVie Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 155 AbbVie Inc.: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 156 AbbVie Inc.: Regional Market Shares, 2022
  • Figure 157 Boehringer Ingelheim GmbH: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 158 Boehringer Ingelheim GmbH: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 159 Boehringer Ingelheim GmbH: Segment Market Shares, 2022
  • Figure 160 Boehringer Ingelheim GmbH: Regional Market Shares, 2022
  • Figure 161 Catalent Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 162 Catalent Inc.: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 163 Catalent Inc.: Segment Market Shares, 2022
  • Figure 164 Catalent Inc.: Regional Market Shares, 2022
  • Figure 165 Lonza: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 166 Lonza: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 167 Lonza: Segment Market Shares, 2022
  • Figure 168 Lonza: Regional Market Shares, 2022
  • Figure 169 Pfizer Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 170 Pfizer Inc.: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 171 Pfizer Inc.: Segment Market Shares, 2022
  • Figure 172 Pfizer Inc.: Regional Market Shares, 2022
  • Figure 173 Samsung Biologics: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 174 Samsung Biologics: Segment Market Shares, 2022
  • Figure 175 Samsung Biologics: Regional Market Shares, 2022
  • Figure 176 WuXi AppTec: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 177 WuXi AppTec: Segment Market Shares, 2022
  • Figure 178 Thermo Fisher Scientific Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 179 Thermo Fisher Scientific Inc.: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 180 Thermo Fisher Scientific Inc.: Segment Market Shares, 2022
  • Figure 181 Thermo Fisher Scientific Inc.: Regional Market Shares, 2022
  • Figure 182 Cytiva: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 183 Cytiva: R&D, 2017-2022 (US$ Million, AGR %)
  • Figure 184 Cytiva: Segment Market Shares, 2022
  • Figure 185 Cytiva: Regional Market Shares, 2022